Suzanne D. Turner

5.4k total citations
117 papers, 2.7k citations indexed

About

Suzanne D. Turner is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Suzanne D. Turner has authored 117 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 35 papers in Molecular Biology and 34 papers in Oncology. Recurrent topics in Suzanne D. Turner's work include Lymphoma Diagnosis and Treatment (34 papers), Prenatal Substance Exposure Effects (14 papers) and Breast Cancer Treatment Studies (11 papers). Suzanne D. Turner is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Prenatal Substance Exposure Effects (14 papers) and Breast Cancer Treatment Studies (11 papers). Suzanne D. Turner collaborates with scholars based in United Kingdom, United States and Canada. Suzanne D. Turner's co-authors include Lukas Kenner, Ricky M. Trigg, Jonathan W. Gunn, Denis R. Alexander, Brenda K. Mann, Olaf Merkel, Thomas G. Cotter, Claire Quiney, Gerda Egger and G.A. Amos Burke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Suzanne D. Turner

112 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne D. Turner United Kingdom 31 833 698 620 518 343 117 2.7k
Yun Jong Lee South Korea 32 771 0.9× 410 0.6× 405 0.7× 265 0.5× 509 1.5× 174 3.7k
Elizabeth A. Beierle United States 31 1.1k 1.3× 181 0.3× 774 1.2× 398 0.8× 797 2.3× 187 3.2k
Zhichao Chen China 29 1.3k 1.6× 169 0.2× 510 0.8× 679 1.3× 234 0.7× 158 3.0k
Jianhua Lin China 29 1.1k 1.3× 388 0.6× 340 0.5× 361 0.7× 784 2.3× 182 3.1k
Sa Wang China 25 786 0.9× 225 0.3× 468 0.8× 241 0.5× 99 0.3× 84 2.7k
Paul Waring Australia 26 492 0.6× 356 0.5× 716 1.2× 258 0.5× 168 0.5× 62 2.0k
Antônio Sérgio Petrilli Brazil 27 606 0.7× 164 0.2× 715 1.2× 275 0.5× 306 0.9× 121 2.4k
Lei Zhao China 30 1.2k 1.4× 311 0.4× 570 0.9× 502 1.0× 159 0.5× 105 2.4k
Yves Benoît Belgium 34 1.2k 1.4× 226 0.3× 694 1.1× 595 1.1× 369 1.1× 139 4.1k
Thomas Wiebe Sweden 30 601 0.7× 401 0.6× 547 0.9× 217 0.4× 443 1.3× 115 2.9k

Countries citing papers authored by Suzanne D. Turner

Since Specialization
Citations

This map shows the geographic impact of Suzanne D. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne D. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne D. Turner more than expected).

Fields of papers citing papers by Suzanne D. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne D. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne D. Turner. The network helps show where Suzanne D. Turner may publish in the future.

Co-authorship network of co-authors of Suzanne D. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne D. Turner. A scholar is included among the top collaborators of Suzanne D. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne D. Turner. Suzanne D. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matthews, Jamie D., Fabio Iannelli, Heinz Fischer, et al.. (2025). HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy. Leukemia. 39(6). 1412–1424. 1 indexed citations
2.
Turner, Suzanne D., et al.. (2024). Pharmacist perceptions of continuing professional development and goal development in a community health-system. Currents in Pharmacy Teaching and Learning. 16(12). 102166–102166. 1 indexed citations
3.
Lim, Megan S., et al.. (2023). Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma. Best Practice & Research Clinical Haematology. 36(1). 101447–101447.
4.
Turner, Suzanne D., et al.. (2023). Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series. European journal of medical research. 28(1). 573–573. 1 indexed citations
5.
Zhang, Qian, Hong Y. Wang, Selene Nuñez-Cruz, et al.. (2022). Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALK. American Journal Of Pathology. 192(8). 1186–1198. 2 indexed citations
6.
Heerden, Jaques van, Joyce Kambugu, Guillermo Chantada, et al.. (2022). Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa. Pediatric Hematology and Oncology. 40(3). 203–223. 5 indexed citations
7.
Mecca, Carmen, Qi Wang, Chiara Ambrogio, et al.. (2021). Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood. 139(5). 717–731. 27 indexed citations
8.
Taj, Mary, Britta Maecker‐Kolhoff, Rebecca E. Ling, et al.. (2021). Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. British Journal of Haematology. 193(6). 1178–1184. 10 indexed citations
9.
Crossland, Rachel E., Sarah Wilkinson, Amir Enshaei, et al.. (2021). Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 36(3). 781–789. 23 indexed citations
10.
Ulferts, Rachel, Elena Marcassa, Beatriz Montaner, et al.. (2021). Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation. Cell Reports. 37(4). 109899–109899. 46 indexed citations
11.
Jahangiri, Leila, Ricky M. Trigg, John A. Williams, et al.. (2021). The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers. International Journal of Molecular Sciences. 22(16). 8527–8527. 20 indexed citations
12.
Kreutmair, Stefanie, Teresa Poggio, Geoffroy Andrieux, et al.. (2020). Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model. Leukemia. 34(12). 3242–3255. 4 indexed citations
13.
14.
Trigg, Ricky M., Jacqui Shaw, & Suzanne D. Turner. (2019). Opportunities and challenges of circulating biomarkers in neuroblastoma. Open Biology. 9(5). 190056–190056. 26 indexed citations
15.
Li, Jing, Carter J. Barger, Adam R. Karpf, et al.. (2019). NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers. 11(8). 1119–1119. 5 indexed citations
16.
Spithoff, Sheryl, et al.. (2017). First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.. PubMed. 63(5). e277–e283. 24 indexed citations
17.
Malcolm, Tim, Patrick Villarèse, Laurence Lamant, et al.. (2016). Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nature Communications. 7(1). 10087–10087. 51 indexed citations
18.
Quiney, Claire, et al.. (2009). Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway. Leukemia. 23(8). 1432–1440. 130 indexed citations
19.
Turner, Suzanne D. & Denis R. Alexander. (2006). Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia. 20(4). 572–582. 24 indexed citations
20.
Turner, Suzanne D., Andrea Ricci, Helen Petropoulos, et al.. (2002). The E2 Ubiquitin Conjugase Rad6 Is Required for the ArgR/Mcm1 Repression of ARG1 Transcription. Molecular and Cellular Biology. 22(12). 4011–4019. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Jong Lee Breakdown of academic impact, for papers by Elizabeth A. Beierle Breakdown of academic impact, for papers by Zhichao Chen Breakdown of academic impact, for papers by Jianhua Lin Breakdown of academic impact, for papers by Sa Wang Breakdown of academic impact, for papers by Paul Waring Breakdown of academic impact, for papers by Antônio Sérgio Petrilli Breakdown of academic impact, for papers by Lei Zhao Breakdown of academic impact, for papers by Yves Benoît Breakdown of academic impact, for papers by Thomas Wiebe
Rankless by CCL
2026